These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 667485)

  • 1. Food-intake and locomotor activity: effects of mazindol and spiperone [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1978 Jun; 63(2):412P-413P. PubMed ID: 667485
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of spiperone on feeding parameters in the rat and interactions with (+)-amphetamine, mazindol or (+/-)-fenfluramine [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1979 May; 66(1):147P-148P. PubMed ID: 454939
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of mazindol on brain dopamine turnover in spiperone-treated rats.
    Fuller RW; Snoddy HD
    J Neural Transm; 1979; 44(1-2):13-9. PubMed ID: 438800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazine.
    Bentall AC; Herberg LJ
    Neuropharmacology; 1980 Aug; 19(8):699-703. PubMed ID: 7191488
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of spiperone alone and in combination with anorectic agents on feeding parameters in the rat.
    Cooper SJ; Sweeney KF
    Neuropharmacology; 1980 Oct; 19(10):997-1003. PubMed ID: 7422077
    [No Abstract]   [Full Text] [Related]  

  • 6. The anorectic action of mazindol.
    Sweeney KF
    Ir J Med Sci; 1978 Aug; 147 Suppl 1():66-70. PubMed ID: 689855
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of spiperone on feeding performance in a food preference test.
    Cooper SJ; Sweeney KF; Toates FM
    Psychopharmacology (Berl); 1979 Jun; 63(3):301-5. PubMed ID: 113819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of selected CNS depressants with d-amphetamine or mazindol on food intake and motor activity of rats.
    Iorio LC; Ryan EA; Gogerty JH
    Eur J Pharmacol; 1976 Mar; 36(1):89-94. PubMed ID: 1261608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of spiperone on self-stimulation and other activities of the Mongolian gerbil.
    Francis N; Marley E; Stephenson JD
    Br J Pharmacol; 1978 May; 63(1):43-9. PubMed ID: 565659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of stimulation by high amphetamine doses following a low dose of spiperone.
    Baez LA; Kerns RD; Smith P
    Eur J Pharmacol; 1977 Jan; 41(1):77-9. PubMed ID: 832667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mazindol reduces food intake in rats via suppression of meal size and meal number.
    Wellman PJ
    J Psychopharmacol; 2008 Jul; 22(5):532-5. PubMed ID: 18208906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mazindol on food intake in ventromedial hypothalamic lesioned rats and glucose absorption in rats.
    Inoue S; Tsuchiya M; Takamura Y
    Int J Obes; 1987; 11 Suppl 3():63-9. PubMed ID: 3440693
    [No Abstract]   [Full Text] [Related]  

  • 15. CuZn-superoxide dismutase transgenic mice: no effect on longevity, locomotor activity and 3H-mazindol and 3H-spiperone binding over 19 months.
    Gallagher IM; Jenner P; Glover V; Clow A
    Neurosci Lett; 2000 Aug; 289(3):221-3. PubMed ID: 10961669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.
    Bignon E; Alonso R; Arnone M; Boigegrain R; Brodin R; Gueudet C; Héaulme M; Keane P; Landi M; Molimard JC; Olliero D; Poncelet M; Seban E; Simiand J; Soubrié P; Pascal M; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1999 May; 289(2):752-61. PubMed ID: 10215649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septal polydipsia in rats is a primary polydipsia not mediated by dopamine.
    Pal GK; Thombre DP
    Indian J Physiol Pharmacol; 1992 Apr; 36(2):101-4. PubMed ID: 1506069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative and motor performance in rats after interference with dopamine neurotransmission with spiroperidol.
    Ranje C; Ungerstedt U
    Eur J Pharmacol; 1977 May; 43(1):39-46. PubMed ID: 193696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects produced by an anticholinergic on the neuroleptic inhibition of motor behaviour and self-stimulation of the prefrontal cortex in the rat.
    Mora F; Alba F; Sanguinetti AM; Rodriguez JM; Vives F
    Brain Res Bull; 1980; 5(3):223-5. PubMed ID: 7397566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.